Product Overview: S Citadep
S Citadep 5 mg Cipla is a pharmaceutical preparation containing escitalopram oxalate, a selective serotonin reuptake inhibitor (SSRI) compound of significant interest in neuropharmacological research. Escitalopram represents the S-enantiomer of citalopram and demonstrates enhanced selectivity for serotonin reuptake inhibition compared to its racemic counterpart. Researchers at Stroid UK Shop utilise this compound to investigate serotonergic neurotransmitter pathways and receptor dynamics in controlled laboratory environments. The compound’s mechanism involves selective blockade of the serotonin transporter protein, leading to increased synaptic serotonin concentrations in experimental models.
Laboratory Applications
This pharmaceutical-grade compound serves multiple research applications in neuroscience and pharmacology laboratories. Scientists examine escitalopram’s effects on serotonin reuptake mechanisms, studying its binding affinity to the serotonin transporter and allosteric modulation properties. Research protocols often investigate the compound’s interaction with other neurotransmitter systems, including noradrenergic and dopaminergic pathways. Comparative studies with other escitalopram formulations help researchers understand pharmacokinetic variations and bioavailability profiles. The compound’s metabolic pathways through cytochrome P450 enzymes provide valuable data for drug interaction studies and metabolite identification research.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Escitalopram Oxalate |
| Strength | 5 mg per tablet |
| Manufacturer | Cipla Limited |
| CAS Number | 219861-08-2 (oxalate salt) |
| Molecular Formula | C20H21FN2O·C2H2O4 |
| Storage Conditions | Room temperature, dry environment |
Advanced analytical techniques including HPLC, mass spectrometry, and NMR spectroscopy enable precise characterisation of this compound’s properties. Researchers studying selective receptor modulators often compare escitalopram’s selectivity profiles with other pharmacological agents. Laboratory investigations frequently examine the compound’s stability under various pH conditions and its interaction with biological matrices.
Research Compliance
All studies involving this compound must maintain strict adherence to institutional review board guidelines and appropriate laboratory safety protocols. Researchers investigating neurotransmitter systems often integrate escitalopram studies with peptide research examining neuroprotective mechanisms. The compound’s well-documented pharmacological profile makes it valuable for comparative pharmacology studies and as a reference standard in serotonin transporter research. This product is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption or clinical applications.
